Tag: degenerative disc disease

DiscGenics receives FDA RMAT designation for IDCT for degenerative disc disease

DiscGenics has announced that the US Food and Drug Administration (FDA) has granted Regenerative Medicine Advanced Therapy (RMAT) designation to Injectable Disc Cell Therapy...

Tritanium posterior lumbar cage an ‘effective alternative’ to PEEK cages for...

For the treatment of degenerative disc disease (DDD), the Tritanium posterior lumbar cage (Stryker) is an effective alternative to polyetheretherketone (PEEK) cages, with higher...

Early study suggests novel, injectable gel may greatly reduce chronic low...

An experimental formulation of a hydrogel, injected into spinal discs, proved safe and effective in substantially relieving chronic low back pain caused by degenerative...

Spine BioPharma completes US$13m Series B financing round

Spine BioPharma, a biopharmaceutical company that aims to develop non-opiate, non-surgical therapies for the treatment of pain and disability from chronic low back pain...

DiscGenics reveals positive interim data of cell therapy for degenerative disc...

DiscGenics has announced positive interim data from its ongoing phase 1/2 clinical trial of IDCT (rebonuputemcel), an allogeneic injectable discogenic cell therapy for degenerative...

Companion Spine raises US$55 million to further develop and market its...

Companion Spine has raised US$55 million in a Series A financing round, with the money going towards the development and commercialisation of its range...

Study supports use of VIA Disc to treat degenerative disc disease

VIVEX Biologics has announced that the initial clinical trial results of the VAST Trial evaluating VIA Disc were published in The International Journal of...

IDCT clinical study passes final safety review

DiscGenics has announced that it has received the go-ahead from an independent data safety monitoring committee (DSMC) to enrol the final 24 patients in...
idct

DiscGenics receives FDA fast track designation for disc degeneration cell therapy

DiscGenics has announced that the US Food and Drug Administration (FDA) has granted fast track designation for its investigational cell therapy, IDCT, currently being...
IDCT

First patients treated in Japanese clinical trial of cell therapy for...

DiscGenics today announced the first patients have been treated in its Japanese safety study, a clinical trial of IDCT for mild to moderate degenerative...
IDCT

Cell therapy IDCT passes initial safety review of first-in-human clinical trial...

It has been announced that IDCT (DiscGenics) has passed the initial planned safety review of its Phase I/II trial evaluating the allogeneic, injectable disc...
IDCT

Clinical evaluation of non-surgical degenerative disc disease treatment to begin in...

The Japanese Pharmaceuticals and Medical Devices Agency (PMDA) has approved a Clinical Trial Notification (CTN) application for IDCT (DiscGenics), an allogenic injectable disc cell...
SpinalCyte logo

SpinalCyte announces sustained 12-month MRI outcomes after CybroCell injection

SpinalCyte has announced that a single injection of modified human dermal fibroblasts (HDFs) resulted in significant improvements of disc height and pain reduction 12...
concorde

DePuy Synthes launches Concorde Lift expandable interbody implant for minimally invasive...

Concorde Lift (DePuy Synthes), a new expandable interbody device, is launching in the USA. The implant is designed to treat patients suffering from degenerative...

SpinalCyte announces MRI evidence of disc regeneration following phase 1/phase 2...

MRI analysis of patients who received intradiscal injections of human dermal fibroblasts shows significant improvement in disc height after six months, the latest evidence...

One step closer to halting the “relentless cascade” of disc degeneration

According to a “Best Paper” presentation at the North American Spine Society annual meeting (NASS; 26–29 October 2016, Boston, USA), it may be possible...

Safety study of Intralink-Spine’s Réjuve nears completion as multicentre pivotal study...

With positive clinical results at the six-month juncture from its early safety and feasibility study in Malaysia, Intralink-Spine, has confirmed that the Réjuve system...

First AxioMed Freedom viscoelastic total disc replacement implanted in Australia

Australia’s first viscoelastic total cervical disc replacement case using the AxioMed Freedom device has been successful performed by Richard Laherty of Queensland Neurosurgery, Brisbane. Laherty...

Study demonstrates improved outcomes with Clarix regenerative matrix as an adjunct...

Amniox Medical has announced results of a prospective randomised clinical study of its proprietary cryopreserved Amniotic Membrane as an adjunct to lumbar discectomy. The...